Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Abivax (ABVX) Operating Margin: 2022-2025

Historic Operating Margin for Abivax (ABVX) over the last 1 years, with Jun 2025 value amounting to 723.22%.

  • Abivax's Operating Margin rose 11467806.00% to 723.22% in Q2 2025 from the same period last year, while for Jun 2025 it was 1,077.06%, marking a year-over-year decrease of 67821.00%. This contributed to the annual value of -1,389.54% for FY2024, which is 136692.00% up from last year.
  • Latest data reveals that Abivax reported Operating Margin of 723.22% as of Q2 2025, which was down 28.49% from 1,011.36% recorded in Q1 2025.
  • Over the past 5 years, Abivax's Operating Margin peaked at 1,011.36% during Q1 2025, and registered a low of -113,954.84% during Q2 2024.
  • Over the past 3 years, Abivax's median Operating Margin value was 361.82% (recorded in 2023), while the average stood at -18,539.35%.
  • Its Operating Margin has fluctuated over the past 5 years, first crashed by 40bps in 2024, then surged by 11,467,806bps in 2025.
  • Quarterly analysis of 4 years shows Abivax's Operating Margin stood at -1,408.70% in 2022, then skyrocketed by 140,912bps to 0.42% in 2023, then tumbled by 40bps to 0.02% in 2024, then soared by 11,467,806bps to 723.22% in 2025.
  • Its last three reported values are 723.22% in Q2 2025, 1,011.36% for Q1 2025, and 0.02% during Q4 2024.